Humanized LL2IGG to Treat Systemic Lupus Erythematosus
ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
|3||Active, not recruiting||
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
† Study has passed its completion date and status has not been verified in more than two years.